Research Article
Cystatin C-Based Equations Detect Hidden Kidney Disease and Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma
Table 2
Chronic kidney disease stage classification of patients with newly diagnosed multiple myeloma depending on the equation employed.
| Stage | eGFR (mL/min) | CKD-EPI-sCr-CysC (gold standard) | CKD-EPI-sCr | CKD-EPI-CysC | CAPA |
| G1 | ≥90 | 5 | 16 | 4 | 3 | G2 | 89–60 | 28 | 24 | 22 | 23 | G3a | 45–59 | 9 | 5 | 7 | 9 | G3b | 30–44 | 4 | 5 | 11 | 11 | G4 | 15–29 | 13 | 9 | 13 | 12 | G5 | <15 | 2 | 2 | 4 | 3 | CKD based on KDIGO guidelines (women/men) | <60 | 28 (10/18) | 21 (6/15) | 35 (14/21) | 35 (14/21) | CKD based on IMWG guidelines (women/men) | <40 | 17 (4/13) | 16 (3/13) | 24 (7/17) | 23 (6/17) |
|
|